The FDA approves three Boston Scientific (BSX +2.3%) pacemakers that are designed to work with...


The FDA approves three Boston Scientific (BSX +2.3%) pacemakers that are designed to work with the company's Latitude NXT system, which allows doctors to monitor patients remotely but hasn't yet received authorization. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs